2015
DOI: 10.7860/jcdr/2015/13846.6382
|View full text |Cite
|
Sign up to set email alerts
|

Inducible Clindamycin Resistance among Clinical Isolates of Staphylococcus aureus from Sub Himalayan Region of India

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
18
3

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(26 citation statements)
references
References 22 publications
5
18
3
Order By: Relevance
“…In different studies, the inducible clindamycin ranged from 0% to 37.1% [ Table 4 ]. [ 7 12 15 16 17 18 19 20 21 22 23 24 25 26 27 ] It was observed that percentage of inducible clindamycin resistance was higher among MRSA (24.8%) compared to MSSA (7.5%). The difference between MSSA and MRSA isolates were not statistically significant ( P = 0.2340).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In different studies, the inducible clindamycin ranged from 0% to 37.1% [ Table 4 ]. [ 7 12 15 16 17 18 19 20 21 22 23 24 25 26 27 ] It was observed that percentage of inducible clindamycin resistance was higher among MRSA (24.8%) compared to MSSA (7.5%). The difference between MSSA and MRSA isolates were not statistically significant ( P = 0.2340).…”
Section: Discussionmentioning
confidence: 99%
“…[ 15 ] In different studies, authors have reported the MS phenotype varies between 0.7% and 44.6% [ Table 4 ]. [ 7 12 15 16 17 18 19 20 21 22 23 24 25 26 27 ] This result implies that clindamycin can be safely and effectively instituted as a therapeutic option in this group of patients even in the presence of macrolide resistance.…”
Section: Discussionmentioning
confidence: 99%
“…A high event of S. aureus strains in IPD setting might be because of comfort in spreading of disease among patients through health care workers and instruments. 7 In this study ( 9%).…”
Section: Discussionmentioning
confidence: 48%
“…Its desirable oral bioavailability has been credited as an excellent option for outpatient treatment and changeover after intravenous antibiotics. However, the rate of inducible clindamycin resistance (iCR) (16.2%) requires an urgent response, and has been previously reported elsewhere [44,45]. The consequence of excessive use of macrolides is responsible for raising resistance in this class of antibiotics.…”
Section: Discussionmentioning
confidence: 99%